Abstract:Abstract2-n-propylquinoline (2-PQ) is a natural compound having interesting anti-leishmanial activities by the oral route but with a rapid elimination rate. 2-PQ is insoluble in water and therefore cannot be administered intravenously. In this study, water-soluble polymeric prodrugs of 2-PQ were synthesized for intravenous administration with the objective of treating patients having severe visceral leishmaniasis with recurrent vomiting. As 2-PQ has no functional groups for tethering onto a soluble polymer, two amine derivatives of 2-PQ, (E)-2-(3-(2-ammonioethoxy)-3-oxoprop-1-en-1-yl)quinolin-1-ium chloride (1) and (E)-2-(3-(2-ammonioethyl)amino)-3-oxoprop-1-en-1-yl)quinolin-1-ium chloride (2), were synthesized and characterized using 1H and 13C NMR, IR, and mass spectroscopy. Both compounds (1) and (2) were soluble in water. They were tethered onto oxidized polyglucose (PG) at ~ 20 wt% concentration via imine linkages susceptible to hydrolysis. In vitro release at 37 °C into phosphate buffer showed that around 75% of both the compounds was released in 24 h. The parent compounds and their conjugates were evaluated for their anti-leishmanial activity both in vitro, and in vivo in a Leishmania donovani/Balb/c mice model. In vitro, the most active compound was (1) with an IC50 value of 5.67 ± 0.0.44 μg/mL against axenic and 8.34 ± 0.74 μg/mL against intramacrophage amastigotes. In vivo, both compounds (1) and (2) were less active at a dose of 10 mg/kg body weight showing a reduction in parasite burden of 30.2 and 21.7% respectively. The conjugates of (1) and (2) with PG were inactive in vivo. Probably, much higher concentrations of the conjugates and prolonged treatment times are necessary for potential anti-leishmanial activity.Lay Summary2-n-propylquinoline (2-PQ) is a natural compound having anti-leishmanial activities by the oral route but with a rapid elimination rate. 2-PQ is insoluble in water and therefore cannot be administered intravenously. As 2-PQ has no functional groups, two amine derivatives of 2-PQ were synthesized and conjugated to oxidized polyglucose. The parent compounds and their conjugates were evaluated for their anti-leishmanial activity both in vitro, and in vivo in a Leishmania donovani/Balb/c mice model. The new compounds were less active compared to AmBisome® both in vitro and in vivo and the conjugates were not active. Possibly, multiple injections and prolonged treatment durations are necessary for better in vivo response.

New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani

In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route

High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo

Design, synthesis, and biological evaluation of quinoline-piperazine/pyrrolidine derivatives as possible antileishmanial agents

Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani

Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis

Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Regioselective Synthesis of Potential Non-Quinonoid Prodrugs of Plasmodione: Antiparasitic Properties Against Two Hemoglobin-Feeding Parasites and Drug Metabolism Studies

Synthesis of New 4-Aminoquinolines and Evaluation of Their In Vitro Activity against Chloroquine-Sensitive and Chloroquine-Resistant Plasmodium falciparum

Determination of drug-like properties of a novel antileishmanial compound: In vitro absorption, distribution, metabolism, and excretion studies

Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a Ph-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1H)-Quinolones with Single Dose Cures.

3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents

Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents

Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine‐1,1‐dioxide derivatives

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches

Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites

Synthesis and leishmanicidal evaluation of sulfanyl- and sulfonyl-tethered functionalized benzoate derivatives featuring a nitroimidazole moiety